|
|
 |
|
Viewing report
|
|
|
|
Japan: Pharmaceutical Market - Future Perspectives (1997 - 2006)
Yano Research Institute Ltd., Pages: 157
Chapter I Health System Reforms and the Pharmaceutical Industry
I. The NHI Drug Price System: Decaying under the Healthcare System Reform
The NHI Drug Price System in Japan
Introduction of the New Drug Pricing System
II. Introduction of the Japanese Version of Drug Reference Pricing System
Why the Drug Reference Pricing System?
Drug Price Reduction and the Drug Reference Pricing System
Issues - The Japanese Version of the Drug Reference Pricing System
III. The Pharmaceutical Industry: In the Midst of Big Change
Reduction of the Drug Cost Ratio: Its Impact to the Industry
Strategies for Survival
Outlook of Business Strategies for Survival
Reorganization of the Pharmaceutical Industry
Appendix: Chronology of Drug Price Changes in Japan
Figures and Charts:
Changes in Total Sales Value of 10 Leading Manufacturers
Changes in Ordinary Profits of 10 Leading Manufacturers
Figures of ManufacturersEFinancial Results
Changes in Sales Value Per Employee: FY1990 - FY1996
Changes in Ordinary Profits Per Employee: FY1990 - FY1996
Changes in Sales Value and Ordinary Profits: FY1985 -FY1996
Changes in Ordinary Profits: FY1993 - FY1997
Changes in Advertisement Expenses: FY1991 - FY1995
Sales Ranking FY1997
Financial Performances of Leading Pharmaceutical Manufacturers
Chapter II The Current and Future of R&D Management
Current Status of the Clinical Trial in Japan and Future Direction
Structural Changes in the Pharmaceutical Business
Clinical Test and the Background
Revision of the Pharmaceutical Affairs Law
Viability of Clinical Trials in Japan
Pharmaceutical Manufacturers and Healthcare Reform Conclusion
Figures and Charts:
Changes in R&D Expenses: FY1993 - FY1997
New Drug Development by Leading Pharmaceutical Manufacturers
Chapter III Future Outlook on the Pharmaceutical Market
I. Healthcare Expense: 420 Billion Yen Reduction
Three Options
Amendment of the Medical Fee System in FY 1998
Double Digit Decrease of NHI Drug Price in 1998 Revision
II. Forecast of the National Healthcare Expense in the 21st Century
Increasing Individual Burden
The National Healthcare Expense: Invisible Factors
III. Estimates for the Drug Production Value in the 21st Century
Doctor’s Responsibility in Drug Treatment
Will Market Growth Rate Decline from FY1997 to 98
Will the Industry Positively Grow in the 21st Century?
Figures and Charts:
National Health Expenditures and GNP/GNI: 1954 - 1995
National Health Expenditures: 1960 -1995
Breakdown of Growth Rates: National Health Expenditures 1986 -1995
Elderly and National Health Expenditures: FY1973 - FY1995
Future Forecast for the National Health Expenditures (Projected by Ministry of Health and Welfare)
Forecasts For the Future National Health Expenditures: FY1996 - FY2010
Changes in the Pharmaceutical Production Value
Forecasts for Future Pharmaceutical Production Value: FY1997 - FY2006
Forecasts for Future Pharmaceutical Production by Therapeutic Category: FY1996 - FY2005
Customers who bought this item also bought
Pharmaceutical Pricing and Distribution in Japan: The keys to success in the world’s second largest market
Pharmaceutical Market and Health Care Reform in China 2008
Pharmaceutical Pricing and Reimbursement in Japan, 2008
Pharmaceutical Pricing and Reimbursement in China
Pharmaceutical Pricing and Reimbursement in Japan
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the First Quarter of 2008
China HealthCare & Pricing System Reform 2008
Pharmaceutical Market Access, Pricing, and Reimbursement News in the Second Quarter of 2009
Pharmaceutical Pricing and Reimbursement: Strategies for Market Access Across the US, Europe, Japan and Other Key Geographies
Strategic Overview of Pharmaceutical Pricing and Reimbursement in the Major Markets
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Second Quarter of 2007
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Fourth Quarter of 2007
|
|
|
|
